Skip to main content
. 2023 Jun 1;15(6):e39818. doi: 10.7759/cureus.39818

Figure 3. Immunohistochemistry of hemangioblastoma tumor.

Figure 3

Immunostaining of the hemangioblastoma tumor showed weak positivity with CD56 antibody panel (A) and inhibin antibody panel (B).